Table 4.
Summary of clinicopathological parameters in prostate samples for ChIP-qPCR
| CASES | TT | NT |
|---|---|---|
| Total cases (n = 65) | 32 | 33 |
| Age at diagnosis (years) | ||
| <49 | 0 | 1 |
| 50-59 | 6 | 10 |
| 60-69 | 17 | 17 |
| >70 | 9 | 5 |
| PSA baseline (ng/mL) | ||
| <4 | 0 | 4 |
| 4-10 | 14 | 23 |
| 10-20 | 8 | 4 |
| >20 | 10 | 2 |
| Clinical stage | ||
| T1c | 17 | - |
| T2a | 7 | - |
| T2b | 6 | - |
| T2c | 1 | - |
| T3 | 1 | - |
| Gleason score | ||
| ≤7 | 19 | - |
| >7 | 13 | - |
TT: tumoral tissues; NT: normal tissues; PSA: prostate-specific antigen.